Project Details
In 2018, Grup Adel executed the technology transfer for a PAP (para-aminophenol) production facility in Türkiye. The project focused exclusively on delivering proprietary process technology to enable efficient and safe production operations. Leveraging our in-house expertise, we provided full process know-how and technical documentation to support the client, PNCB, in establishing local manufacturing capabilities in alignment with international standards.
Project Info
Value
1.5 M euro
Date
2018
Client
Türkiye
Advancing Pharmaceutical Technology in Türkiye
Technology Transfer for PAP Production Plant – 2018
In 2018, Grup Adel successfully executed a technology transfer project for a PAP (Para-Aminophenol) production plant in Türkiye, commissioned by PNCB (Türkiye). The project, valued at €1.5 million, focused exclusively on transferring specialized process knowledge — with no equipment procurement involved.
This initiative reflects Grup Adel’s dedication to enabling industrial advancement through intellectual and technical empowerment. By providing advanced production technology along with comprehensive documentation and expert guidance, we laid the groundwork for a safe, efficient, and compliant pharmaceutical manufacturing process.
Key Project Highlights
Transfer of advanced PAP production technology
Delivered from a top-tier global technology provider, ensuring high process efficiency and consistency.Complete process documentation and know-how
Included PFDs, P&IDs, process descriptions, control strategies, and safety protocols customized to the client’s needs.Client-focused engineering advisory
Technical materials were adapted to align with PNCB’s regulatory and operational framework.Ethical, transparent execution
Managed in full alignment with Grup Adel’s values of safety, integrity, and professional responsibility.Support for local capability building
By focusing on technology instead of physical supply, the project contributed to sustainable industrial development in Türkiye.
This project demonstrates Grup Adel’s ability to deliver high-value, knowledge-based solutions that empower our partners across borders — helping build self-sufficient and modern production ecosystems in the pharmaceutical industry.
